top of page

Research and screening of Alzheimer’s and Parkinson’s using egSEQ Amplicon panels

Existing diagnosis and treatment of Alzheimer’s and Parkinson’s disease occur when the disease has already progressed to a relatively advanced stage. egSEQ Amplicon panels offer clinicians and researchers a highly specific and cost-effective screening and research solution, with low sample input requirements and a simple workflow.

For researchers part of the UK's largest study on neurodegenerative diseases, egSEQ Amplicon panels provide a set of tools to examine genetic variants related to the brain with clinical accuracy on patients suffering from Alzheimer’s and Parkinson’s, which could represent a major step forwards in our understanding of these conditions that impact millions of people worldwide.'

Related Links:

  1. egSEQ NGS

  2. egSEQ Customised Panels

  3. egSEQ Whole Exome

  4. Genetic Services

#NeurologicalDiseases #egSEQCustomisedPanels

bottom of page